UCCIFERRI, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 1.566
NA - Nord America 1.533
AS - Asia 578
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.682
Nazione #
US - Stati Uniti d'America 1.528
IT - Italia 348
IE - Irlanda 306
CN - Cina 266
SE - Svezia 249
UA - Ucraina 208
GB - Regno Unito 163
TR - Turchia 158
FR - Francia 98
DE - Germania 79
IN - India 64
SG - Singapore 62
FI - Finlandia 42
RU - Federazione Russa 42
VN - Vietnam 18
CZ - Repubblica Ceca 7
BE - Belgio 6
CH - Svizzera 5
HK - Hong Kong 5
CA - Canada 4
NL - Olanda 4
AR - Argentina 3
AT - Austria 3
BG - Bulgaria 2
BR - Brasile 1
ES - Italia 1
EU - Europa 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
Totale 3.682
Città #
Chandler 365
Dublin 298
Jacksonville 268
Southend 146
Princeton 127
Ashburn 99
Izmir 92
Nanjing 88
Chieti 56
Altamura 55
Beijing 51
Dearborn 43
Wilmington 42
Cambridge 40
Ann Arbor 37
Singapore 35
Nanchang 31
Boardman 29
Pune 22
Dong Ket 18
New York 16
Seattle 16
Kunming 15
Pescara 15
Washington 15
Milan 14
Rome 12
Grevenbroich 11
Hebei 11
Shenyang 11
Tianjin 10
Woodbridge 10
Norwalk 9
Hangzhou 8
Jiaxing 7
Brussels 6
Changsha 6
Jinan 6
Helsinki 5
Houston 5
Lanzhou 5
Los Angeles 5
Albenga 4
Aquila 4
Brno 4
Changchun 4
Frankfurt am Main 4
Hong Kong 4
Montesilvano 4
Moscow 4
Munich 4
Orange 4
Pianella 4
Putignano 4
San Mateo 4
San Vito Chietino 4
Giulianova 3
L'aquila 3
Molise 3
New Delhi 3
Olomouc 3
Tappahannock 3
Taranto 3
Vienna 3
Amsterdam 2
Auburn Hills 2
Bari 2
Berazategui 2
Chicago 2
Civitanova Marche 2
Francavilla al Mare 2
Guangzhou 2
Hefei 2
Herndon 2
Kirkland 2
Lanciano 2
London 2
Malatya 2
Mumbai 2
Ningbo 2
Novara 2
Olathe 2
Padova 2
Pizzoli 2
Prato 2
Redwood City 2
Rouen 2
San Nicola la Strada 2
Sofia 2
Taizhou 2
Teramo 2
Termoli 2
Toronto 2
Turin 2
Villa Rosa 2
Alghero 1
Ardabil 1
Baotou 1
Belgrade 1
Boydton 1
Totale 2.307
Nome #
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 95
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 90
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 89
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 88
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 85
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 85
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 82
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 78
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 75
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 74
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 74
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 72
Acute urinary retention due to HSV-1: a case report 72
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 72
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 71
Hypertension in HIV: Management and Treatment 70
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 69
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 68
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 67
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 66
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 65
High dose of erythropoietin in management of interferon/ribavirin induced anemia 65
Inguinal lymphadenopathy due to Bartonella henselae 65
Antiretroviral therapy management and rationalisation of available resources 65
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 64
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 64
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 64
Canakinumab in a subgroup of patients with COVID-19 64
Periodontitis and cytokine patterns in HIV positive patients 63
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 63
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 63
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 63
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 60
Proteinuria in an African HIV-infected patient: effects of telmisartan. 60
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 60
null 60
Normal breathing releases SARS-CoV-2 into the air 60
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis. 59
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 59
Infected atrial mixoma: a rare cause of fever 58
Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection 58
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 58
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 56
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 54
Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people. 54
Prevalence of HPV infection among HIV-positive and HIV-negative women in central/eastern Italy: Strategies of prevention 52
Pidotimod and Immunological Activation in Individuals Infected with HIV 50
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 50
Use of direct renin inhibitor in an HIV positive subject. 49
Efficacy of canakinumab in mild or severe COVID-19 pneumonia 49
Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons. 48
Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features 48
A rare case of acute tubular necrosis tenofovir alafenamide-related 46
Parameters associated with diagnosis of COVID-19 in emergency department 45
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV 45
Circulating extracellular vesicles as new inflammation marker in hiv infection 44
Optimization of comorbidity therapy to achieve sustained viral response in HCV patients. 41
High Prevalence of Human Papillomavirus Type 58 in HIV infected men who have sex with men: A preliminary report in Central Italy 37
COVID-19 in a patient with SISTEMIC sclerosis: The role of ruxolitinib 36
Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients 32
Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation 28
Molnupiravir as an Early Treatment for COVID-19: A Real Life Study 27
New Therapeutic Options in Mild Moderate COVID-19 Outpatients 24
Role of monoclonal antibody drugs in the treatment of COVID-19 23
Are monoclonal antibodies effective in patients with severe obesity in SARS‐CoV‐2 infected? 20
Early detection of pleuro-pulmonary tuberculosis by bedside lung ultrasound: A case report and review of literature 19
Ultrasound imaging of the axilla 17
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 17
Inflammatory Markers in HIV+ Patients and Cardiovascular Risk 17
Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation 13
Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen 12
Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience 10
Antimicrobial resistance in intensive care patients hospitalized with SEPSIS: a comparison between the COVID-19 pandemic and pre-pandemic era 10
Analysis of Patients’ Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis 8
Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey 7
It is Not Always COVID-19: Case Report about an Undiagnosed HIV Man with Dyspnea 5
Recombinant Human Angiotensin-Converting Enzyme 2 and COVID-19 Acute Respiratory Distress Syndrome: A Theoretical or a Real Resource? 5
Totale 4.000
Categoria #
all - tutte 16.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.352


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020617 177 41 14 19 57 29 65 54 38 52 60 11
2020/2021398 47 3 59 5 41 73 13 14 29 46 31 37
2021/2022364 20 10 11 80 22 8 17 27 21 17 34 97
2022/20231.084 80 171 67 110 105 200 60 91 124 14 30 32
2023/2024625 41 27 45 31 54 171 132 43 2 8 6 65
2024/202574 74 0 0 0 0 0 0 0 0 0 0 0
Totale 4.000